Skip to main content
PepStack
Blutwerte · Marker

Eisen

Serum Iron · Serumeisen · Fe

Eisen & AnämieNüchtern erforderlichZeitabhängig
Einheit:
µmol/L
Abbreviation
Fe

Serum iron measures the amount of iron bound to transferrin in the bloodstream.

Reference Ranges

Reference
11.631.3µmol/L
11.6
15
25
31.3
LowNormalHigh
Reference
Optimal
Unit · µmol/L

Ranges may vary slightly based on laboratory and population. Consider sex-specific differences.

Overview

Übersicht

Serum iron, also known as Eisen or Fe, is a blood biomarker that quantifies the amount of circulating iron bound to transferrin in the bloodstream. It plays a crucial role in oxygen transport and storage, as well as in various enzymatic processes. Researchers have found that serum iron levels are indicative of iron metabolism and homeostasis in the body. Clinically, serum iron is significant in diagnosing and managing conditions such as iron deficiency anemia (IDA), hereditary hemochromatosis, and anemia of chronic disease. Low serum iron levels are often associated with IDA, characterized by microcytosis and hypochromia, while elevated levels may indicate hemochromatosis or other iron overload disorders. For athletes and biohackers, maintaining optimal serum iron levels is essential for peak performance and endurance, as iron is vital for hemoglobin synthesis and oxygen delivery to muscles. However, excessive iron can lead to oxidative stress and tissue damage, highlighting the importance of balanced levels. Researchers observed that serum iron levels can be influenced by various factors, including dietary intake, circadian rhythms, and acute inflammation. It is recommended to measure serum iron in the morning, fasting, to minimize diurnal variation and interference from recent food intake or supplements.

Klinische Bedeutung

Reduced serum iron levels indicate iron deficiency anemia or anemia of chronic disease. Elevated levels suggest conditions like hereditary hemochromatosis or iron overload.

Dynamics

Trend Interpretation

Rising Values

Progressively rising serum iron levels may suggest iron overload conditions like hemochromatosis. Retest in 4 weeks if levels remain elevated.

Falling Values

Falling serum iron levels may indicate worsening iron deficiency or increased loss. Investigate underlying causes.

Re-test Interval

4 weeks if outside optimal range

Etiology

Causes — High & Low

Cause

Elevated Levels

  • Hereditary hemochromatosis
  • Iron supplementation
  • Repeated blood transfusions
  • Liver disease
  • Hemolytic anemia
Cause

Low Levels

  • Iron deficiency anemia
  • Chronic blood loss
  • Malabsorption syndromes
  • Chronic kidney disease
  • Inflammatory states
Protocol

How to Optimize

Lever

Lifestyle

  • Regular monitoring of iron levels
  • Avoidance of unnecessary iron supplementation
  • Regular physical activity
  • Stress management
Lever

Nutrition

  • Increased intake of iron-rich foods
  • Consumption of vitamin C to enhance iron absorption
  • Avoidance of tea or coffee with meals
Lever

Supplementation

  • Iron supplements if deficient
  • Vitamin C to enhance absorption

Note:

Consult a physician before starting iron supplements, especially if not diagnosed with deficiency.

Testing Guidelines

🍽️Fasting Required
🕐Time-Sensitive

Iron levels are highest in the morning; testing is recommended at this time for consistency.

Testing Frequency

Annually for healthy adults, more frequently if managing a condition.

Interfering Factors

  • Recent iron supplementation
  • Acute inflammation
  • Menstrual cycle

Related Peptides & Hormones

Hepcidin

May affect

hormone or peptide

Open Research Questions

Current research suggests that reference ranges for serum ferritin and transferrin saturation in diverse populations remain debated, particularly in relation to age and gender variations. Researchers have not yet established optimal targets for iron levels in specific conditions like chronic disease or pregnancy. Additionally, unanswered clinical questions include the precise mechanisms of hepcidin regulation and the best strategies for managing iron overload in hereditary hemochromatosis.

24 Research Publications

823

Total Citations

8

Human/RCT

4.9

Avg. Influence

2025

Latest

Sort
Filter
#01

Evaluation of anemia in children.

ReviewInfluence8.0
179
This study evaluated anemia in children, noting that it is often asymptomatic and detected through screening. Researchers found that mild microcytic anemia may be treated with oral iron, while severe cases require further investigation for potential blood loss. The classification of anemia into microcytic, normocytic, and macrocytic is crucial for appropriate management.
View on PubMed
#02

Iron overload syndromes and the liver.

ReviewInfluence7.0
159
This article reviewed the conditions leading to iron accumulation in the liver. Researchers discussed the diagnostic tools available to pathologists for assessing iron overload, including histologic examination and laboratory iron tests. The review emphasizes the importance of understanding the underlying causes of iron accumulation for accurate diagnosis.
View on PubMed
#03

Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.

ReviewInfluence11.0
107
This study contrasted serotonin syndrome (SS) and neuroleptic malignant syndrome (NMS), both of which can arise from psychotropic medications. Researchers observed that NMS is distinguished by low serum iron levels and specific laboratory profiles, while SS presents with different clinical features. The findings underscore the importance of accurate diagnosis for effective management.
View on PubMed
#04

Meta-Analysis of Copper and Iron in Parkinson's Disease Brain and Biofluids.

Meta-AnalysisInfluence2.0
79
This meta-analysis assessed copper and iron levels in Parkinson's disease. Researchers confirmed that iron levels were elevated in the substantia nigra of Parkinson's patients, while copper levels were decreased. Additionally, serum iron was found to be lower in Parkinson's disease compared to controls, highlighting the complex role of these metals in the disease.
View on PubMed
#05

Diagnosing iron deficiency: Controversies and novel metrics.

Rusch Jody A, et al. · Best practice & research. Clinical anaesthesiology · 2023

ReviewInfluence4.0
56
This review examined the diagnostic challenges of iron deficiency, focusing on established and novel biomarkers. Researchers found that traditional markers like serum iron and ferritin, along with newer metrics like soluble transferrin receptor, are essential for accurate diagnosis. The study aimed to improve understanding of iron metabolism and its implications for patient care.

Key findings

  1. 01Researchers observed that established markers like serum iron and ferritin are commonly used but have limitations.
  2. 02The review identified novel biomarkers, such as soluble transferrin receptor and hepcidin, which may enhance diagnosis.
  3. 03Researchers noted the importance of distinguishing between different types of anemia to improve clinical outcomes.
View on PubMed
#06

Anemia of chronic disease.

Review
55
This study focused on anemia of chronic disease (ACD), which is common among hospitalized patients. Researchers found that ACD is characterized by low serum iron and normal or increased ferritin levels, distinguishing it from iron deficiency anemia. The study highlighted that successful treatment of underlying conditions often alleviates ACD.
View on PubMed
#07

Evaluation of microcytosis.

Van Vranken Michele · American family physician · 2010

Review
49
This study evaluated microcytosis as an incidental finding in patients. Researchers observed that the most common causes include iron deficiency anemia and thalassemia trait, with serum ferritin measurement being the first recommended test. The findings stress the importance of identifying the underlying cause of microcytosis for proper management.

Key findings

  1. 01The primary causes of microcytosis include iron deficiency anemia and thalassemia trait.
  2. 02Low serum ferritin levels indicate iron deficiency, which is often linked to blood loss.
  3. 03Further tests may be needed if ferritin levels are normal, including assessments of iron levels and hemoglobin types.
View on PubMed
#08

Changes in micronutrient and inflammation serum biomarker concentrations after a norovirus human challenge.

Human
38
This study modeled the inflammatory response to norovirus infection and its impact on micronutrient biomarkers. Researchers observed that inflammation affected serum concentrations of ferritin and hepcidin, while serum iron and transferrin saturation decreased during the inflammatory response. The findings highlight the need to consider inflammation when assessing nutritional status.
View on PubMed
#09

Revisiting Iron Metabolism, Iron Homeostasis and Iron Deficiency Anemia.

Review
31
This review examined iron deficiency anemia (IDA), highlighting its prevalence among children, women of childbearing age, and the elderly. Researchers found that IDA is characterized by low serum iron, decreased transferrin saturation, and low ferritin levels, with an estimated 2 billion people affected globally. The review emphasized the importance of identifying underlying causes for effective management.
View on PubMed
#10

Iron and iron-related proteins in alcohol consumers: cellular and clinical aspects.

Review
26
This review focused on the relationship between alcohol consumption and iron metabolism. Researchers observed that alcohol consumers often exhibit dysregulation of iron levels, which can complicate the diagnosis and management of alcohol-associated liver disease. The study provides insights into the alterations of iron parameters in this population.
View on PubMed

Clinical Trials (10)

10

Total Trials

1,103

Total Enrolled

Absorption of Iron From Stabilized Lactoferrin: A Study in Women With Iron Deficiency

NCT07394972RECRUITING
Sponsor

Nicole Stoffel

Enrollment

45

Started

2026

Primary outcome

Fractional iron absorption (%)

Iron Deficiency (Without Anemia)

Effect of Chitin and Ascorbic Acid on Dietary Insect Iron Absorption

NCT06822062RECRUITING
Sponsor

Swiss Distance University of Applied Sciences

Enrollment

25

Started

2025

Primary outcome

Fractional iron absorption

Iron Deficiency (Without Anemia)

Investigation of the Effects of Curcumin and Resveratrol Supplements Added to the Mediterranean Diet on Disease Severity and Inflammatory Biomarkers in Patients With Ulcerative Colitis

NCT05761327COMPLETED
Sponsor

Ardahan University

Enrollment

48

Started

2022

Primary outcome

Inflammatory Bowel Disease Questionnaire (IBDQ)

Ulcerative Colitis

Potential of Prebiotic Galacto-oligosaccharides in Improving Efficacy and Safety of Oral Iron Supplementation in HIV-infected Children

NCT04931641COMPLETED
Sponsor

Swiss Federal Institute of Technology

Enrollment

86

Started

2021

Primary outcome

Iron status: Serum Ferritin (ug/L) (SF)

Iron DeficiencyHIV

Serum Bovine Immunoglobulin (SBI) in Children and Young Adults With Inflammatory Bowel Disease (IBD)

NCT04223518Early Phase 1TERMINATED
Sponsor

Monisha Hitesh Shah

Enrollment

6

Started

2020

Primary outcome

Effects of Serum Bovine Immunoglobulin (SBI) on nutrition of pediatric patients with inflammatory Bowel Disease

Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease

Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency

NCT03079518Phase 2COMPLETED
Sponsor

RWTH Aachen University

Enrollment

23

Started

2017

Primary outcome

changes in blood intact FGF23 after infusion of 1000 mg ferric carboxymaltose

Heart Failure, SystolicIron Deficiency

Potential Adverse Developmental and Nutritional Consequences of Helicobacter Pylori Infection in Israeli Children

Sponsor

Hillel Yaffe Medical Center

Enrollment

600

Started

2016

Primary outcome

Changes in means of differences in height

Helicobacter Pylori InfectionIron Deficiency AnemiaChild Development

Optimizing Iron Suppletion After Roux-en-Y Gastric Bypass

NCT02271997Phase 4COMPLETED
Sponsor

Rijnstate Hospital

Enrollment

120

Started

2014

Primary outcome

normal value serum ferritin

Iron Deficiency

HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis

NCT01784939COMPLETED
Sponsor

Rennes University Hospital

Enrollment

31

Started

2013

Primary outcome

distribution of values of Hepcidin / ferritin plasma ratio

Hereditary Hemochromatosis C282Y Homozygous

Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)

NCT00707876Phase 2COMPLETED
Sponsor

AMAG Pharmaceuticals, Inc.

Enrollment

119

Started

2008

Primary outcome

Segment-level Sensitivity and Specificity of VE-MRI at 3 Ferumoxytol Dosing Levels and Differences in Sensitivity and Specificity by Dose Group

Peripheral Arterial Disease (PAD)

Publication Trend

Research publications about Eisen over time

9total
1
'75
2
'92
1
'10
1
'12
1
'15
1
'20
1
'21
1
'23

Track your bloodwork in PepStack

Log lab results, track trends and optimize your biomarkers over time.

Legal Disclaimer

This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer